Cargando…

Advances of Patient-Derived Organoids in Personalized Radiotherapy

Patient-derived organoids (PDO), based on the advanced three-dimensional (3D) culture technology, can provide more relevant physiological and pathological cancer models, which is especially beneficial for developing and optimizing cancer therapeutic strategies. Radiotherapy (RT) is a cornerstone of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yuenan, Li, Ye, Sheng, Zonghai, Deng, Weiwei, Yuan, Hongyan, Wang, Shubin, Liu, Yajie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9102799/ https://www.ncbi.nlm.nih.gov/pubmed/35574360 http://dx.doi.org/10.3389/fonc.2022.888416

Ejemplares similares

Patient-Derived Organoid Serves as a Platform for Personalized Chemotherapy in Advanced Colorectal Cancer Patients
por: Geevimaan, Khamushavalli, et al.
Publicado: (2022)

Synthetic CT Generation Based on T2 Weighted MRI of Nasopharyngeal Carcinoma (NPC) Using a Deep Convolutional Neural Network (DCNN)
por: Wang, Yuenan, et al.
Publicado: (2019)

Patient-Derived Organoids in Precision Medicine: Drug Screening, Organoid-on-a-Chip and Living Organoid Biobank
por: Zhou, Zilong, et al.
Publicado: (2021)

Patient-Derived Organoid Facilitating Personalized Medicine in Gastrointestinal Stromal Tumor With Liver Metastasis: A Case Report
por: Cao, Ying, et al.
Publicado: (2022)

Evaluation of Hybrid VMAT Advantages and Robustness Considering Setup Errors Using Surface Guided Dose Accumulation for Internal Lymph Mammary Nodes Irradiation of Postmastectomy Radiotherapy
por: Zhang, Zhe, et al.
Publicado: (2022)

Screening of an individualized treatment strategy for an advanced gallbladder cancer using patient-derived tumor xenograft and organoid models
por: Tan, Dengxu, et al.
Publicado: (2022)

Patient-Derived Tumor Organoids: New Progress and Opportunities to Facilitate Precision Cancer Immunotherapy
por: Wang, Ji, et al.
Publicado: (2022)

Patient-Derived Cancer Organoids as Predictors of Treatment Response
por: Verduin, Maikel, et al.
Publicado: (2021)

Patient-derived rectal cancer organoids—applications in basic and translational cancer research
por: Yan, Yumeng, et al.
Publicado: (2022)

Paranasal Sinus Invasion Should Be Classified as T4 Disease in Advanced Nasopharyngeal Carcinoma Patients Receiving Radiotherapy
por: Zhao, Yajie, et al.
Publicado: (2020)

Patient‐Derived Organoids Can Guide Personalized‐Therapies for Patients with Advanced Breast Cancer
por: Chen, Ping, et al.
Publicado: (2021)

Patient-Derived Nasopharyngeal Cancer Organoids for Disease Modeling and Radiation Dose Optimization
por: Lucky, Sasidharan Swarnalatha, et al.
Publicado: (2021)

Safety of PD-1/PD-L1 Inhibitors Combined With Palliative Radiotherapy and Anti-Angiogenic Therapy in Advanced Hepatocellular Carcinoma
por: Zhong, Liting, et al.
Publicado: (2021)

Metabolic Heterogeneity in Patient Tumor-Derived Organoids by Primary Site and Drug Treatment
por: Sharick, Joe T., et al.
Publicado: (2020)

Nivolumab and Hypofractionated Radiotherapy in Patients With Advanced Lung Cancer: ABSCOPAL-1 Clinical Trial
por: Ye, Hua, et al.
Publicado: (2021)

Molecular Biomarker of Drug Resistance Developed From Patient-Derived Organoids Predicts Survival of Colorectal Cancer Patients
por: Chen, Lifeng, et al.
Publicado: (2022)

Patient‐derived organoids for personalized gallbladder cancer modelling and drug screening
por: Yuan, Bo, et al.
Publicado: (2022)

Imaging-Based Machine Learning Analysis of Patient-Derived Tumor Organoid Drug Response
por: Spiller, Erin R., et al.
Publicado: (2021)

Patient-derived xenografts or organoids in the discovery of traditional and self-assembled drug for tumor immunotherapy
por: Zhang, Wei, et al.
Publicado: (2023)

The Distribution of Pelvic Nodal Metastases in Prostate Cancer Reveals Potential to Advance and Personalize Pelvic Radiotherapy
por: Filimonova, Irina, et al.
Publicado: (2021)

Advances in Radiobiology of Stereotactic Ablative Radiotherapy
por: Qiu, Bin, et al.
Publicado: (2020)

Impact of Preoperative vs Postoperative Radiotherapy on Overall Survival of Locally Advanced Breast Cancer Patients
por: Deng, Yujiao, et al.
Publicado: (2021)

Standardizing Patient-Derived Organoid Generation Workflow to Avoid Microbial Contamination From Colorectal Cancer Tissues
por: Marinucci, Mattia, et al.
Publicado: (2022)

A deep learning model for drug screening and evaluation in bladder cancer organoids
por: Zhang, Shudi, et al.
Publicado: (2023)

Advance in integrating platinum-based chemotherapy with radiotherapy for locally advanced nasopharyngeal carcinoma
por: Zhu, Fubin, et al.
Publicado: (2023)

Comparison of Oncological Outcomes Between Radical Prostatectomy and Radiotherapy by Type of Radiotherapy in Elderly Prostate Cancer Patients
por: Guo, Xiao-Xiao, et al.
Publicado: (2021)

Organoid: Next-Generation Modeling of Cancer Research and Drug Development
por: Liu, Jungang, et al.
Publicado: (2022)

Medical Imaging Biomarker Discovery and Integration Towards AI-Based Personalized Radiotherapy
por: Pang, Yaru, et al.
Publicado: (2022)

Application of Patient-Derived Cancer Organoids to Personalized Medicine
por: Shiihara, Masahiro, et al.
Publicado: (2022)

Application of Organoids in Carcinogenesis Modeling and Tumor Vaccination
por: Wang, Zeyu, et al.
Publicado: (2022)

Effect of Abdominal Circumference on the Irradiated Bowel Volume in Pelvic Radiotherapy for Rectal Cancer Patients: Implications for the Radiotherapy-Related Intestinal Toxicity
por: Wang, Gang, et al.
Publicado: (2022)

Establishment of Organoids From Human Epithelioid Sarcoma With the Air-Liquid Interface Organoid Cultures
por: Wakamatsu, Toru, et al.
Publicado: (2022)

Editorial: Advances in radiotherapy for prostate cancer
por: Kamran, Sophia C., et al.
Publicado: (2022)

Mitigation of the Interplay Effects of Combining 4D Robust With Layer Repainting Techniques in Proton-Based SBRT for Patients With Early-Stage Non-small Cell Lung Cancer
por: Wei, Long, et al.
Publicado: (2020)

Pancreatic cancer derived 3D organoids as a clinical tool to evaluate the treatment response
por: Shukla, Hem D, et al.
Publicado: (2023)

Editorial: Intraoperative Radiotherapy (IORT)—A New Frontier for Personalized Medicine as Adjuvant Treatment and Treatment of Locally Recurrent Advanced Malignancy
por: Thomas, Tarita O., et al.
Publicado: (2018)

Patient-derived organoids facilitating individual therapy in an adolescent with embryonal rhabdomyosarcoma of the cervix: a case report and literature review
por: Qiao, Xinyu, et al.
Publicado: (2023)

Organoids from patient biopsy samples can predict the response of BC patients to neoadjuvant chemotherapy
por: Shu, Dan, et al.
Publicado: (2022)

Efficacy of concurrent radiotherapy in patients with locally advanced rectal cancer and synchronous metastasis receiving systemic therapy
por: Yin, Tzu-Chieh, et al.
Publicado: (2023)

Patient‐derived renal cell carcinoma organoids for personalized cancer therapy
por: Li, Zhichao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nd8d3harfjgv29pp9gqt74cj16